Webinar: Accelerating Topical Development for All Routes of Delivery
Join us in this free webinar where we’re sharing our expertise in breaking through boundaries in formulation development using in vitro models. Beyond skin: Accelerating product development for non-traditional routes of delivery
Register for this free webinar here.
Whether via the eye, skin, lungs, nose, or mucosal membranes these alternative routes offer key advantages alongside presenting unique challenges. To ensure a patient-centric approach, pharmaceutical product developers are increasingly looking away from traditional routes of delivery and dosage forms (solid oral, intravenous).
The key to accelerating development in this area is the use of viable relevant human tissue in vitro models to optimize the drug or drug product to de-risk clinical trial and investment decisions. These models provide a measure of biological efficacy prior to the clinic and without translational concerns from animal models.
Join MedPharm’s Chief Technology Officer, Dr. Jon Lenn, as he discusses:
- The challenges and opportunities of targeting these routes of delivery
- Approaches to de-risk product development to boost chances of success
- The latest advances in in vitro models based on human tissue to create meaningful data investors and regulators trust
- Case Studies: Where these models have been used to significantly influence programs and ensure success